Close

Analyst Ratings for Flexion Therapeutics (FLXN)

FLXN Rating Summary

  |   Expand Research on FLXN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.1 / 10   Percentile Rank: 64%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/19/2021 Northland Capital Markets Carl Byrnes Downgrade Market Perform
(Outperform)
N/A
(N/A)
9.12
(9.12)
0% Details
10/19/2021 H.C. Wainwright N/A Downgrade Neutral
(Buy)
10.00
(N/A)
9.31
(9.12)
-2.04% Details